Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jan 9;41(3):1658–1668. doi: 10.3892/or.2019.6960

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright: © Zakelj et al.

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

PMC Copyright notice

Figure 3. — Antitumor effectiveness of electrochemotherapy with cisplatin (A) or bleomycin (B). Kaplan-Meier survival curves of the mice with radiosensitive (FaDu) or radioresistant (FaDu-RR) tumors after treatment with i.v. injection of cisplatin (CDDP) or bleomycin (BLM) alone, or in combination with electrical pulses-electrochemotherapy (ECT), and after treatment with electrical pulses alone (EP). *P<0.05 between FaDu and FaDu-RR tumor model after ECT with CDDP, n=5–7 mice. CTRL, control group.